Simon Quick Advisors LLC acquired a new position in shares of Relx Plc (NYSE:RELX - Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 4,779 shares of the technology company's stock, valued at approximately $241,000.
A number of other hedge funds have also recently bought and sold shares of RELX. Bank of America Corp DE raised its holdings in shares of Relx by 4.2% in the 4th quarter. Bank of America Corp DE now owns 6,246,462 shares of the technology company's stock worth $283,714,000 after purchasing an additional 253,107 shares during the period. Lazard Asset Management LLC lifted its position in shares of Relx by 1.2% during the 4th quarter. Lazard Asset Management LLC now owns 4,224,334 shares of the technology company's stock valued at $191,868,000 after buying an additional 48,793 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Relx by 4.0% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,189,886 shares of the technology company's stock worth $144,885,000 after acquiring an additional 121,831 shares during the period. Ameriprise Financial Inc. increased its holdings in Relx by 368.7% in the 4th quarter. Ameriprise Financial Inc. now owns 2,807,038 shares of the technology company's stock worth $127,437,000 after acquiring an additional 2,208,119 shares during the last quarter. Finally, Northern Trust Corp increased its holdings in Relx by 51.6% in the 4th quarter. Northern Trust Corp now owns 2,191,588 shares of the technology company's stock worth $99,542,000 after acquiring an additional 745,532 shares during the last quarter. 15.02% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of equities analysts have weighed in on the stock. Morgan Stanley reiterated an "overweight" rating on shares of Relx in a research report on Wednesday, April 16th. Barclays upgraded shares of Relx from an "equal weight" rating to an "overweight" rating in a research note on Friday, March 14th. The Goldman Sachs Group began coverage on shares of Relx in a report on Wednesday, March 26th. They set a "buy" rating on the stock. Finally, Wall Street Zen lowered Relx from a "buy" rating to a "hold" rating in a research note on Tuesday, March 4th. One investment analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Buy".
Read Our Latest Report on Relx
Relx Price Performance
NYSE RELX traded down $0.16 on Thursday, hitting $52.34. The stock had a trading volume of 701,973 shares, compared to its average volume of 730,010. The firm has a 50-day moving average of $53.45 and a 200-day moving average of $50.07. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52. Relx Plc has a 52-week low of $43.45 and a 52-week high of $56.33. The company has a market capitalization of $98.27 billion, a price-to-earnings ratio of 28.14, a price-to-earnings-growth ratio of 3.19 and a beta of 0.84.
Relx Profile
(
Free Report)
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Further Reading

Before you consider Relx, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.
While Relx currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.